Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 866 entries
View as:

Special Investigation in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01947816 Org: User:
Start: 08/09/13 End: 02/15/18 Due: 02/15/19

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06009237 Org: User:
Start: 08/23/23 End: 10/30/23 Due: 10/30/24

A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06078202 Org: User:
Start: 12/01/24 End: 01/31/25 Due: 01/31/26

A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06174688 Org: User:
Start: 12/12/23 End: 09/13/24 Due: 09/13/25

Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT03894956 Org: User:
Start: 05/02/19 End: 11/10/21 Due: 11/10/22

A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan

Phase: N/A Priority: Normal
NCT ID: NCT06362044 Org: User:
Start: 06/07/23 End: 12/31/24 Due: 12/31/25

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04195698 Org: User:
Start: 01/15/20 End: 09/11/23 Due: 09/11/24

A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06151535 Org: User:
Start: 12/19/23 End: 02/24/25 Due: 02/24/26

A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT06346288 Org: User:
Start: 04/24/24 End: 12/27/25 Due: 12/27/26

A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05068284 Org: User:
Start: 01/31/22 End: 07/20/23 Due: 07/20/24

An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Phase: N/A Priority: Normal
NCT ID: NCT06439394 Org: User:
Start: 06/17/24 End: 07/18/24 Due: 07/18/25

An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04189614 Org: User:
Start: 02/13/20 End: 12/31/24 Due: 12/31/25

A Study to Evaluate Adverse Events and How Single Ascending Doses of ABBV-141 Move Through the Body of Healthy Adult Western and Asian Participants

Phase: N/A Priority: Normal
NCT ID: NCT06148181 Org: User:
Start: 01/29/24 End: 12/30/24 Due: 12/30/25

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

Phase: N/A Priority: Normal
NCT ID: NCT03569293 Org: User:
Start: 08/13/18 End: 09/09/25 Due: 09/09/26

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Phase: N/A Priority: Normal
NCT ID: NCT01652157 Org: User:
Start: 07/31/12 End: 04/08/20 Due: 04/08/21

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03875508 Org: User:
Start: 06/04/19 End: 08/25/20 Due: 08/25/21

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03557619 Org: User:
Start: 07/30/19 End: 03/21/26 Due: 03/21/27

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02803138 Org: User:
Start: 07/07/16 End: 10/21/18 Due: 10/21/19

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Phase: N/A Priority: Normal
NCT ID: NCT02675426 Org: User:
Start: 12/17/15 End: 03/10/22 Due: 03/10/23

An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT05841537 Org: User:
Start: 06/09/23 End: 07/31/28 Due: 07/31/29

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Phase: N/A Priority: Normal
NCT ID: NCT01817530 Org: User:
Start: 04/08/13 End: 12/31/15 Due: 12/31/16

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02819999 Org: User:
Start: 10/31/16 End: 05/31/19 Due: 05/31/20

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06603558 Org: User:
Start: 09/24/24 End: 05/31/29 Due: 05/31/30

Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

Phase: N/A Priority: Normal
NCT ID: NCT02485600 Org: User:
Start: 10/19/15 End: 02/26/20 Due: 02/26/21

A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06614192 Org: User:
Start: 11/08/24 End: 04/30/29 Due: 04/30/30